Kanya Rajangam

Company: Senti Biosciences Inc.

Job title: President, Head of Research & Development & Chief Medical Officer

Seminars:

Highlighting Key Clinical Readouts in the Application of NK Cells to Haematological Malignancies to Further NK Therapy Development 10:00 am

Discussing key successes thus far in clinic of Senti-202 in AML Sharing lessons learned and next stepsRead more

day: Conference Day One